Methamnetamine

Methamnetamine (also known as MNA or N-methyl-2-AI) is a psychoactive drug and research chemical that is structurally related to methamphetamine and 2-AI. It is known for its stimulant effects, which are similar to those of other amphetamine-like substances.

History

Methamnetamine was first synthesized in the early 21st century as part of a wave of new psychoactive substances. It was initially sold online as a "legal high" or "research chemical," often marketed as an alternative to illegal stimulants like methamphetamine or MDMA.

Pharmacology

Methamnetamine is a monoamine releasing agent, meaning it increases the levels of certain chemicals in the brain. Specifically, it is thought to increase the levels of dopamine, norepinephrine, and serotonin, which are neurotransmitters associated with feelings of pleasure, energy, and mood regulation.

Effects

The effects of methamnetamine can vary widely depending on the dose, the individual's physiology, and the context in which it is used. Common effects reported by users include increased energy, euphoria, increased sociability, and heightened sensory perception. However, it can also cause negative effects such as anxiety, paranoia, and physical discomfort.

Legal Status

The legal status of methamnetamine varies by country. In some places, it is classified as a controlled substance, while in others it is legal to possess and use. It is important to note that even in places where it is legal, it may still be associated with significant health risks.

Health Risks

Like other stimulants, methamnetamine can put a significant strain on the heart and circulatory system. It can also cause psychological effects such as anxiety and paranoia, and in some cases, it may trigger a psychotic episode. Long-term use can lead to dependence and addiction.

See Also

• Amphetamine
• Methamphetamine
• Research Chemicals
• Psychoactive Drugs